title: What is adequate management to preserve erectile function after unilateral nerve-sparing radical prostatectomy?
authors.affiliation: Second Department of Urology and Center for Sexual and Reproductive Health, Aristotle University of Thessaloniki, Greece. kchatzim@med.auth.gr
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Hatzimouratidis
authors.forename: Kyriakos
authors.initials: K
authors.lastname: Moysidis
authors.forename: Athanasios
authors.initials: A
authors.lastname: Bekos
authors.forename: Alexandros
authors.initials: A
authors.lastname: Giakoumelos
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Hatzichristou
mesh_terms: D007172:Erectile Dysfunction / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011467:Prostate / Q000294:innervation* / Q000601:surgery*; D011468:Prostatectomy / Q000009:adverse effects*
chemical_list: D010726:Phosphodiesterase Inhibitors